Publications by authors named "Wendy J C Prager-van der Smissen"

9Publications

Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

Authors:
Jingjing Liu Wendy J C Prager-van der Smissen J Margriet Collée Manjeet K Bolla Qin Wang Kyriaki Michailidou Joe Dennis Thomas U Ahearn Kristiina Aittomäki Christine B Ambrosone Irene L Andrulis Hoda Anton-Culver Natalia N Antonenkova Volker Arndt Norbert Arnold Kristan J Aronson Annelie Augustinsson Päivi Auvinen Heiko Becher Matthias W Beckmann Sabine Behrens Marina Bermisheva Leslie Bernstein Natalia V Bogdanova Nadja Bogdanova-Markov Stig E Bojesen Hiltrud Brauch Hermann Brenner Ignacio Briceno Sara Y Brucker Thomas Brüning Barbara Burwinkel Qiuyin Cai Hui Cai Daniele Campa Federico Canzian Jose E Castelao Jenny Chang-Claude Stephen J Chanock Ji-Yeob Choi Melissa Christiaens Christine L Clarke Fergus J Couch Kamila Czene Mary B Daly Peter Devilee Isabel Dos-Santos-Silva Miriam Dwek Diana M Eccles A Heather Eliassen Peter A Fasching Jonine Figueroa Henrik Flyger Lin Fritschi Manuela Gago-Dominguez Susan M Gapstur Montserrat García-Closas José A García-Sáenz Mia M Gaudet Graham G Giles Mark S Goldberg David E Goldgar Pascal Guénel Christopher A Haiman Niclas Håkansson Per Hall Patricia A Harrington Steven N Hart Mikael Hartman Peter Hillemanns John L Hopper Ming-Feng Hou David J Hunter Dezheng Huo Hidemi Ito Motoki Iwasaki Milena Jakimovska Anna Jakubowska Esther M John Rudolf Kaaks Daehee Kang Renske Keeman Elza Khusnutdinova Sung-Won Kim Peter Kraft Vessela N Kristensen Allison W Kurian Loic Le Marchand Jingmei Li Annika Lindblom Artitaya Lophatananon Robert N Luben Jan Lubiński Arto Mannermaa Mehdi Manoochehri Siranoush Manoukian Sara Margolin Shivaani Mariapun Keitaro Matsuo Tabea Maurer Dimitrios Mavroudis Alfons Meindl Usha Menon Roger L Milne Kenneth Muir Anna Marie Mulligan Susan L Neuhausen Heli Nevanlinna Kenneth Offit Olufunmilayo I Olopade Janet E Olson Håkan Olsson Nick Orr Sue K Park Paolo Peterlongo Julian Peto Dijana Plaseska-Karanfilska Nadege Presneau Brigitte Rack Rohini Rau-Murthy Gad Rennert Hedy S Rennert Valerie Rhenius Atocha Romero Matthias Ruebner Emmanouil Saloustros Rita K Schmutzler Andreas Schneeweiss Christopher Scott Mitul Shah Chen-Yang Shen Xiao-Ou Shu Jacques Simard Christof Sohn Melissa C Southey John J Spinelli Rulla M Tamimi William J Tapper Soo H Teo Mary Beth Terry Diana Torres Thérèse Truong Michael Untch Celine M Vachon Christi J van Asperen Alicja Wolk Taiki Yamaji Wei Zheng Argyrios Ziogas Elad Ziv Gabriela Torres-Mejía Thilo Dörk Anthony J Swerdlow Ute Hamann Marjanka K Schmidt Alison M Dunning Paul D P Pharoah Douglas F Easton Maartje J Hooning John W M Martens Antoinette Hollestelle

Sci Rep 2020 06 16;10(1):9688. Epub 2020 Jun 16.

Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-020-65665-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297796PMC
June 2020

MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.

PLoS One 2019 7;14(5):e0216400. Epub 2019 May 7.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0216400PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504094PMC
January 2020

Understanding drugs in breast cancer through drug sensitivity screening.

Springerplus 2015 15;4:611. Epub 2015 Oct 15.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Postbus 2040, 's-Gravendijkwal 230, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40064-015-1406-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628005PMC
November 2015

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.

Cancer Lett 2012 Jun 24;319(1):49-55. Epub 2011 Dec 24.

Erasmus MC, Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2011.12.031DOI Listing
June 2012